Taiwan's Lumosa Therapeutics advances ischemic stroke drug with US FDA feedbackLT3001 aims to extend treatment window from 4.5 to 24 hoursNov. 28, 2025 11:43# Lumosa Therapeutics# ischemic strokeLT3001 aims to extend treatment window from 4.5 to 24 hours# Lumosa Therapeutics# ischemic stroke
